Botulinum Toxin Injection Technique for Reducing the Masseter Size and Enhancing the Jawline.
Abstract
[BACKGROUND] The injection of botulinum toxin into the masseter muscle is an important method for improving hypertrophy. However, some patients may experience adverse reactions, such as sagging of the lower jaw. Therefore, we proposed a method of injecting botulinum toxin into the masseter and platysma muscles that would reduce masseter size and enhance the jawline.
[OBJECTIVES] The aim of this study was to reduce the masseter size while enhancing the jawline.
[METHODS] Twenty patients received botulinum toxin injections into the masseter and platysma muscles. Pain levels were evaluated with the visual analog scale. All patients were photographed before and 6 months after treatment. Evaluations were performed based on standardized criteria. The lift index, reduction index, and symmetry index were performed to assess the degree of jawline elevation, masseter size reduction, and jawline symmetry before and after treatment.
[RESULTS] The mean visual analog scale score of the 20 patients was 2.80 (±1.24). The mean lift index score decreased from 4.93 (±0.34) to 4.53 (±0.37), P < .05. The mean reduction index score decreased from 3.13 (±0.27) to 2.74 (±0.27), P < .05. The mean symmetry index score changed from 0.0393 (±0.0296) to 0.0257 (±0.0246), P < .05.
[CONCLUSIONS] Botulinum toxin injections into the masseter and platysma muscles through nerve block reduced the masseter size, elevated the jawline, and improved symmetry.
[OBJECTIVES] The aim of this study was to reduce the masseter size while enhancing the jawline.
[METHODS] Twenty patients received botulinum toxin injections into the masseter and platysma muscles. Pain levels were evaluated with the visual analog scale. All patients were photographed before and 6 months after treatment. Evaluations were performed based on standardized criteria. The lift index, reduction index, and symmetry index were performed to assess the degree of jawline elevation, masseter size reduction, and jawline symmetry before and after treatment.
[RESULTS] The mean visual analog scale score of the 20 patients was 2.80 (±1.24). The mean lift index score decreased from 4.93 (±0.34) to 4.53 (±0.37), P < .05. The mean reduction index score decreased from 3.13 (±0.27) to 2.74 (±0.27), P < .05. The mean symmetry index score changed from 0.0393 (±0.0296) to 0.0257 (±0.0246), P < .05.
[CONCLUSIONS] Botulinum toxin injections into the masseter and platysma muscles through nerve block reduced the masseter size, elevated the jawline, and improved symmetry.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 5 | |
| 해부 | lower jaw
|
하악골 | dict | 1 | |
| 해부 | Masseter
|
scispacy | 1 | ||
| 해부 | masseter muscle
|
scispacy | 1 | ||
| 해부 | platysma muscles
|
scispacy | 1 | ||
| 해부 | jawline
|
scispacy | 1 | ||
| 약물 | Jawline
|
scispacy | 1 | ||
| 약물 | ±0.0296
|
scispacy | 1 | ||
| 약물 | [BACKGROUND]
|
scispacy | 1 | ||
| 약물 | [OBJECTIVES]
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS] Botulinum toxin
|
scispacy | 1 | ||
| 질환 | hypertrophy
|
C0020564
Hypertrophy
|
scispacy | 1 | |
| 질환 | Pain
|
C0030193
Pain
|
scispacy | 1 | |
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | jawline
|
scispacy | 1 |
MeSH Terms
Humans; Masseter Muscle; Female; Injections, Intramuscular; Adult; Botulinum Toxins, Type A; Male; Middle Aged; Treatment Outcome; Hypertrophy; Neuromuscular Agents; Cosmetic Techniques; Pain Measurement; Young Adult
📑 인용 관계
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.